Every Form 4 that Torm Plc (TRMD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TRMD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TRMD filings page.
TORM plc (TRMD) reported an insider-related transaction involving its Chief Financial Officer, Kim Balle. On 2026-08-27, Balle’s spouse purchased 254 Class A Common Shares of TORM at DKK 196.00 per share, reported as indirect ownership. Balle expressly disclaims beneficial ownership of these 254 shares. A separate line reflects 510 Class A Common Shares held directly after the reported date.
TORM plc Chief Executive Officer Jacob Balslev Meldgaard reported a combination of equity award exercises and share sales. On May 20, 2026, Restricted Stock Units vested and were settled into 170,133 Class A Common Shares at exercise prices tied to $20.51 and $22.47 per share equivalents. Around the same time, he sold a total of 549,147 Class A Common Shares in open-market transactions at prices ranging from about $31.93 to $32.30 per share. Following these transactions, he reports no directly held Class A Common Shares, while retaining 1,180,533 Restricted Stock Units representing rights to receive additional shares.
Meldgaard Jacob Balslev reported acquisition or exercise transactions in this Form 4 filing.
TORM plc reported that Chief Executive Officer Jacob Balslev Meldgaard received a grant of 225,200 Restricted Stock Units (RSUs) linked to the company’s Class A common shares. This is a compensation-related award, not an open-market purchase or sale.
The RSUs were granted on April 10, 2026 and represent a contingent right to receive an equal number of Class A common shares upon vesting. They vest in three equal annual installments on January 1, 2027, January 1, 2028, and January 1, 2029, provided he continues serving the company through each vesting date. No shares were issued at grant; each vested RSU will later settle into one share.
The grant uses a DKK 167.70 grant-date reference price that the company applies only for internal valuation and tax withholding calculations. Following this award, Meldgaard’s directly held derivative position reported in this filing totals 1,265,600 units, illustrating a substantial ongoing equity-based stake aligned with shareholder interests.